Abstract
We performed intravesical instillation of epirubicin in 53 patients with the aim of preventing recurrence of bladder tumors. The patients had undergone transurethral resection of superficial bladder tumors (only transitional-cell carcinoma) within the preceding week, between January of 1990 and July of 1991. Recurrence was found in 11.3% (6/53) of cases during follow-up periods lasting from 1 to 20 months. Side effects occurred in 5.7% (3/53) of the patients. The cumulative nonrecurrence rate was 96.0% for a follow-up period of 6 months and 78.4% for 12 months. The results of this study suggest that intravesical instillation of epirubicin is very useful as adjuvant therapy after transurethral resection of superficial bladder tumors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Melekos MD, Dauaher H, Fokaefs E, Barbalias G (1992) Intravesical instillations of 4-epi-doxorubicin (epirubicin) in the prophylactic treatment of superficial bladder cancer: results of a controlled prospective study. J Urol 147: 371
Niijima T, et al (1986) Cooperative phase II study of epirubicin (EPI) for bladder cancer, renal pelvic and ureteral tumors —Urological Cooperative Study Group of EPI. Acta Urol Jpn 32: 1359
Ozaki Y, et al (1986) Prophylactic intravesical instillation therapy with Adriamycin (ADM) and mitomycin C (MMC) in patients with superficial bladder cancer. Jpn J Urol 77: 1493
Sasaki M, et al (1989) Postoperative intravesical chemotherapy for superficial bladder carcinoma. Nishinihon J Urol 51: 823
Tachibana M, et al (1989) Comparative study on prophylactic intravesical instillation of bacillus Calmette-Guérin (BCG) and adriamycin for superficial bladder cancers. Jpn J Urol 80: 1459
Takashi M, Murase T, Mitsuya H, Mizuno S, Hamajima N, Aoki K, Ohno Y (1987) Statistical analysis of factors affecting recurrence in superficial bladder cancer. Jpn J Urol 78: 39
Tsushima T (1985) Fundamental studies on intravesical instillation of 4′-epi-adriamycin for treatment of bladder cancer. Acta Urol Jpn 31: 1945
Van der Meijden APM, Kurth KH, Oosterlinck W, Debruyne FMJ, the EORTC GU Group (1992) Intravesical therapy with Adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group. Cancer Chemother Pharmacol 30 [Suppl]: S95
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Watanabe, N., Miyagawa, I., Higasibori, Y. et al. Phase II study of intravesical chemoprophylaxis of epirubicin after transurethral resection of bladder tumors. Cancer Chemother. Pharmacol. 35 (Suppl 1), S57–S59 (1994). https://doi.org/10.1007/BF00686921
Issue Date:
DOI: https://doi.org/10.1007/BF00686921